Raising the bar for market authorisation of new drugs
Naci, H.
, Cylus, J., Vandoros, S., Sato, A. & Perampaladas, K.
(2012).
Raising the bar for market authorisation of new drugs.
The BMJ,
345, e4261-e4261.
https://doi.org/10.1136/bmj.e4261
, Cylus, J., Vandoros, S., Sato, A. & Perampaladas, K.
(2012).
Raising the bar for market authorisation of new drugs.
The BMJ,
345, e4261-e4261.
https://doi.org/10.1136/bmj.e4261
Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options.